Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket

Published 20/09/2023, 13:19
Updated 20/09/2023, 14:40
© Reuters.  Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.

Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) shares rose 53.2% to $0.8887 in pre-market trading after the company announced its Board of Directors has approved a plan of liquidation and dissolution.

EBET, Inc. (NASDAQ: EBET) shares rose 32.7% to $0.0702 in pre-market trading.

Exscientia plc (NASDAQ: EXAI) shares jumped 25.6% to $6.36 in pre-market trading. Exscientia and Merck announced collaboration on AI-driven drug discovery in oncology, neuroinflammation, and immunology.

Histogen Inc. (NASDAQ: HSTO) shares gained 21.5% to $0.48 in pre-market trading. Histogen shares fell 40% on Tuesday after the company announced its Board of Directors approved a Plan of Dissolution.

Rail Vision Ltd. (NASDAQ: RVSN) rose 20.5% to $0.6020 in pre-market trading after gaining over 5% on Tuesday.

Avinger, Inc. (NASDAQ: AVGR) shares surged 14.5% to $11.97 in pre-market trading on continued strength after the company on Monday announced the commercial launch of its Tigereye ST image-guided CTO crossing device.

Inhibikase Therapeutics, Inc. (NASDAQ: IKT) rose 13.6% to $1.15 in pre-market trading after falling 33% on Tuesday.

Microbot Medical Inc. (NASDAQ: MBOT) gained 13.3% to $1.86 in pre-market trading after falling 11% on Tuesday.

Cheche Group Inc. (NASDAQ: CCG) shares climbed 8.9% to $35.25 in pre-market trading after falling 56% on Tuesday.

Losers

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) fell 46.8% to $3.51 in pre-market trading after the FDA issued a Complete Response Letter for ARS Pharma's neffy® Epinephrine nasal spray, with request for additional study.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares fell 30.2% to $0.1375 in pre-market trading after jumping 160% on Tuesday.

Bird Global, Inc. (NYSE: BRDS) shares fell 19.5% to $1.15 in pre-market trading. Bird Global shares jumped more than 103% on Tuesday after the company announced its purchase of micromobility operator Skinny Labs for $19 million.

TD Holdings, Inc. (NASDAQ: GLG) fell 13.2% to $0.15 in pre-market trading after gaining 7% on Tuesday.

AgileThought, Inc. (NASDAQ: AGIL) shares fell 12.5% to $0.1471 in pre-market trading after gaining 14% on Tuesday.

Elutia Inc. (NASDAQ: ELUT) fell 9.1% to $1.50 in pre-market trading after jumping 33% on Tuesday. The company announced a $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.

Digital Transformation Opportunities Corp. (NASDAQ: DTOC) fell 8.3% to $12.56 in pre-market after dipping 53% on Tuesday.

Cybin Inc. (NASDAQ: CYBN) fell 6.3% to $0.4119 in pre-market trading. Hedge fund owner Steve Cohen recently invested $19 million in the company.

Revance Therapeutics, Inc. (NASDAQ: RVNC) fell 5.8% to $13.01 in pre-market trading. Revance Therapeutics shares fell 17% on Tuesday after the company said it commenced a plan to exit the OPUL payments business and expects to record a restructuring charge of up to $7 million.

Rail Vision Ltd. (NASDAQ: RVSN) fell 4.1% to $0.47 in pre-market trading after gaining over 5% on Tuesday.

Now Read This: General Mills, FedEx And 3 Stocks To Watch Heading Into Wednesday

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.